Westend Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88K Hold
313
﹤0.01% 215
2025
Q4
$2.24K Hold
313
﹤0.01% 208
2025
Q3
$3.34K Hold
313
﹤0.01% 216
2025
Q2
$3.03K Sell
313
-180
-37% -$1.86K ﹤0.01% 194
2025
Q1
$7.34K Buy
493
+30
+6% +$461 ﹤0.01% 131
2024
Q4
$6.91K Hold
463
﹤0.01% 142
2024
Q3
$8.86K Hold
463
﹤0.01% 136
2024
Q2
$9.4K Hold
463
﹤0.01% 106
2024
Q1
$8.7K Buy
+463
New +$7.95K ﹤0.01% 129

Other funds holding OGN

Westend Capital Management's OGN Position: Q1 2026 in Review

Westend Capital Management held its Organon & Co (OGN) position steady in Q1 2026 at 313 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #215.

Westend Capital Management first reported a position in OGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $9.4K in Q2 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Westend Capital Management held 313 shares of Organon & Co worth $1.88K as of Q1 2026.
  • Westend Capital Management left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Westend Capital Management's portfolio in Q1 2026, its #215 holding.
  • Westend Capital Management first reported a position in Organon & Co in Q1 2024 and has held it in 9 quarters since.
  • Westend Capital Management's Organon & Co position peaked at $9.4K in Q2 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Westend Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.